SCHEMBL10016120

SCHEMBL10016120

Cc1cc(OCc2ccccc2)c2c(c1)O[C@H](c1cc(OCc3ccccc3)c(OCc3ccccc3)c(OCc3ccccc3)c1)[C@@H](O)C2

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ STING1 Q86WV6 1/20 0.46
▸ ABCB1 P08183 3/20 0.46
▸ PTGS1 P23219 4/20 0.42
▸ CYP3A4 P08684 2/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ MAPK14 Q16539 1/20 0.42
▸ BACE1 P56817 2/20 0.38
▸ SNCA P37840 2/20 0.38
▸ SYNJ2 O15056 1/20 0.38
▸ PTGS2 P35354 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ ALOX15 P16050 1/20 0.38
▸ APEX1 P27695 1/20 0.38
▸ RECQL P46063 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38
▸ CNR1 P21554 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5839219 0.93 STING1 (0.43) STING1ABCB1PTGS1CYP3A4MAPK1
SCHEMBL26481191 0.91 ABCB1 (0.41) STING1ABCB1PTGS1CYP3A4MAPK1
SCHEMBL15450257 0.89 CYP3A4 (0.44) ABCB1PTGS1CYP3A4MAPK1BACE1
SCHEMBL15450263 0.89 CYP3A4 (0.44) ABCB1PTGS1CYP3A4MAPK1BACE1
SCHEMBL15450266 0.89 CYP3A4 (0.44) ABCB1PTGS1CYP3A4MAPK1BACE1
SCHEMBL16016915 0.89 CYP3A4 (0.44) ABCB1PTGS1CYP3A4MAPK1BACE1
SCHEMBL24983403 0.88 ABCB1 (0.52) STING1ABCB1PTGS1CYP3A4MAPK1
SCHEMBL10016121 0.88 STING1 (0.45) STING1ABCB1CETP
SCHEMBL513123 0.88 ABCB1 (0.52) STING1ABCB1PTGS1CYP3A4MAPK1
SCHEMBL30892442 0.88 ABCB1 (0.52) STING1ABCB1PTGS1CYP3A4MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9399631-B2 Polyphenol proteasome inhibitors, synthesis, and methods of use UNIVERSITY OF SOUTH FLORIDA (US) 2016-07-26 — — US disclosed
US-20140045931-A1 POLYPHENOL PROTEASOME INHIBITORS, SYNTHESIS, AND METHODS OF USE THE HONG KONG POLYTECHNIC UNIVERSITY (HK) 2014-02-13 — — US disclosed
US-8563607-B2 Polyphenol proteasome inhibitors, synthesis, and methods of use UNIVERSITY OF SOUTH FLORIDA (US) 2013-10-22 — — US disclosed
US-20120029067-A1 Polyphenol Proteasome Inhibitors, Synthesis, and Methods of Use UNIVERSITY OF SOUTH FLORIDA (US) 2012-02-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140045931-A1 POLYPHENOL PROTEASOME INHIBITORS, SYNTHESIS, AND METHODS OF USE PSMC1, PSMB5, PSMC5 STING1 3665/4885ABCB1 2639/4885PTGS1 1774/4885
US-20120029067-A1 Polyphenol Proteasome Inhibitors, Synthesis, and Methods of Use PSMC1, PSMB5, PSMC5 STING1 3665/4885ABCB1 2639/4885PTGS1 1774/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback